| Ticker | AMGN |
|---|---|
| ISIN | US0311621009 |
| Sector | Atención sanitaria |
| Industria | Drug Manufacturers - General |
| Mercado | NASDAQ |
| Capitalización | 177.999.072.599 € |
| Beta | 0,47 |
| Último dividendo | 9,6600 US$ |
| Sitio web | https://www.amgen.com |
| CEO | Robert A. Bradway |
| Fecha de IPO | 17/06/1983 |
| País | US |
| Dirección | One Amgen Center Drive, Thousand Oaks, CA, 91320-1799 |
| Volumen | 3.821.061 |
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-...
El precio actual de Amgen (AMGN) es de 324,29 , con una variación del -1,68%.
Amgen opera en el sector Healthcare, industria Drug Manufacturers - General.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones